The evolving role of specific estrogen receptor modulators (SERMs)

Area of Science:

• Reproductive Medicine
• Oncology
• Pharmacology

Background:

• Estrogen therapy is effective for postmenopausal issues but limited by fears of carcinogenic effects on the uterus and breast.
• Estrogen is contraindicated in breast cancer survivors.
• Selective estrogen receptor modulators (SERMs) act as estrogen antagonists in the uterus and breast but agonists elsewhere.

Purpose of the Study:

• To review the literature on SERMs for postmenopausal women's health and breast cancer prevention.
• To discuss the effects of menopause on women's health and socioeconomic factors.
• To evaluate current and investigational SERMs, including their mechanisms, metabolism, and therapeutic roles.

Main Methods:

• A comprehensive literature review was conducted from January 1995 to June 1999.
• Searches were performed using Medline and Cancer Lit databases.
• Included reports focused on menopausal problems, SERMs, and breast cancer.

Main Results:

• Existing SERMs do not alleviate menopausal vasomotor and urogenital symptoms.
• SERMs exhibit antagonist effects on the uterus and breast, and agonist effects on bones, cardiovascular system, and brain.
• The review covers SERM mechanisms, metabolism, dosing, and antitumor activity.

Conclusions:

• SERMs present a potential alternative to estrogen for postmenopausal women, particularly those with a history of breast cancer.
• Further research is needed to fully understand the role of SERMs in managing menopausal symptoms and preventing breast cancer.
• SERMs offer a targeted approach to hormone-related health concerns in postmenopausal women.